Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 16.46% |
| 3 | Healthcare | 15.81% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.2B | 1.1% |
8,627,536
+2,599,414
| +43% | +$326M |
|
27
Vertex Pharmaceuticals
VRTX
$137B
| $1.2B | 1.1% |
6,202,493
+1,139,486
| +23% | +$203M |
|
28
PayPal
PYPL
$45.9B
| $1.19B | 1.1% |
13,573,826
-1,851,290
| -12% | -$163M |
|
29
Estee Lauder
EL
$37.4B
| $1.19B | 1.1% |
8,198,571
-642,808
| -7% | -$89.2M |
|
30
Workday
WDAY
$50.6B
| $1.12B | 1.04% |
7,701,472
+252,921
| +3% | +$35.1M |
|
|
RHT
31
DELISTED
Red Hat Inc
RHT
| $1.09B | 1.01% |
8,014,447
-175,149
| -2% | -$25.1M |
|
32
BioMarin Pharmaceuticals
BMRN
$12.5B
| $1.05B | 0.97% |
10,844,238
-744,393
| -6% | -$74.3M |
|
33
Corpay
CPAY
$26.8B
| $1.01B | 0.93% |
4,430,365
-168,005
| -4% | -$36.7M |
|
34
Goldman Sachs
GS
$301B
| $897M | 0.83% |
4,000,259
-252,982
| -6% | -$58.8M |
|
35
Caterpillar
CAT
$368B
| $857M | 0.79% |
5,617,710
-824,901
| -13% | -$117M |
|
|
SPLK
36
DELISTED
Splunk Inc
SPLK
| $843M | 0.78% |
6,971,292
-111,315
| -2% | -$12.3M |
|
|
CXO
37
DELISTED
CONCHO RESOURCES INC.
CXO
| $812M | 0.75% |
5,317,534
-120,468
| -2% | -$17M |
|
|
38
Broadcom
AVGO
$1.75T
| $811M | 0.75% |
32,873,480
-24,516,660
| -43% | -$550M |
|
|
39
Intuitive Surgical
ISRG
$132B
| $796M | 0.73% |
4,161,729
+3,685,254
| +773% | +$654M |
|
|
40
Booking.com
BKNG
$155B
| $789M | 0.73% |
9,944,950
-4,787,525
| -32% | -$377M |
|
41
Albemarle
ALB
$16.2B
| $788M | 0.73% |
7,896,101
+565,127
| +8% | +$54.7M |
|
42
Parker-Hannifin
PH
$125B
| $763M | 0.7% |
4,145,742
-711,933
| -15% | -$122M |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $736M | 0.68% |
8,228,124
+2,748,302
| +50% | +$243M |
|
44
Texas Instruments
TXN
$236B
| $734M | 0.68% |
6,839,884
-42,608
| -0.6% | -$4.74M |
|
|
45
McDonald's
MCD
$188B
| $721M | 0.66% |
4,307,717
-2,315,450
| -35% | -$371M |
|
|
XYZ
46
Block Inc
XYZ
$50.2B
| $712M | 0.66% |
7,193,288
+275,166
| +4% | +$21.2M |
|
47
PNC Financial Services
PNC
$96.6B
| $608M | 0.56% |
4,466,833
-2,054,051
| -31% | -$292M |
|
|
48
S&P Global
SPGI
$131B
| $597M | 0.55% |
3,055,356
+2,246,219
| +278% | +$464M |
|
49
Chipotle Mexican Grill
CMG
$48.1B
| $377M | 0.35% |
41,513,450
+23,342,450
| +128% | +$222M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $339M | 0.31% |
1,779,659
+139,195
| +8% | +$25.6M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.